Gozzetti Alessandro, Davis Elizabeth M, Espinosa Rafael, Fernald Anthony A, Anastasi John, Le Beau Michelle M
Section of Hematology/Oncology, Departments of Medicine, University of Chicago, Chicago, Illinois 60637, USA.
Cancer Res. 2002 Oct 1;62(19):5523-7.
Chromosomal rearrangements involving the immunoglobulin heavy chain gene (IGH) at 14q32 are observed in approximately 50% of patients with B-cell non-Hodgkin's lymphoma (NHL). The 5' end of the IGH gene is located within 8 kb of the telomeric repeats of 14q. Translocations involving the IGH locus and the telomeric band of a partner chromosome are difficult to identify, because most terminal bands of human chromosomes appear pale by conventional G-banding techniques. To determine whether there are cryptic translocations involving the IGH locus, we used dual-color fluorescence in situ hybridization (FISH) of 5' and 3' IGH genomic clones containing the variable sequences, or the J(H) and the 5' constant regions, respectively. We examined cells from 51 patients with B-cell NHL who had a normal karyotype (3 patients), clonal abnormalities not involving 14q32 (35 patients), or alterations of 14q32 other than recurring translocations, i.e., add(14)(q32) (13 patients). FISH detected 17 IGH translocations in 16 of 51 (31%) cases. Of the 13 cases with add(14)(q32), FISH identified the partner chromosome in 9 cases (69%; 3q27, 6 cases; 2p13, 19p13.3, and 18q21.3, 1 case each). Six of thirty-eight (16%) patients without visible alterations of 14q32 and 2 of 13 (15%) patients with an abnormality of one chromosome 14 had masked (5 patients) or cryptic IGH translocations (3 patients), involving 3q27 (3 patients), 5p15.3 (2 patients), 19p13.3 (3 patients), or 14q32 (1 patient; 1 patient had two rearrangements). We identified two novel, recurring, cryptic translocations: t(5;14)(p15.3;q32) (2 patients) and t(14;19)(q32;p13.3) (3 patients). In summary, FISH permitted the detection of cryptic or masked IGH rearrangements in approximately 20% of lymphoma cases without visible rearrangements of 14q32 analyzed retrospectively.
在大约50%的B细胞非霍奇金淋巴瘤(NHL)患者中可观察到涉及14q32处免疫球蛋白重链基因(IGH)的染色体重排。IGH基因的5'端位于14q端粒重复序列的8 kb范围内。涉及IGH基因座和伙伴染色体端粒带的易位很难识别,因为通过传统的G显带技术,人类染色体的大多数末端带看起来都很淡。为了确定是否存在涉及IGH基因座的隐匿易位,我们分别使用了包含可变序列或J(H)和5'恒定区的5'和3'IGH基因组克隆进行双色荧光原位杂交(FISH)。我们检查了51例B细胞NHL患者的细胞,这些患者具有正常核型(3例)、不涉及14q32的克隆异常(35例)或除复发性易位以外的14q32改变,即add(14)(q32)(13例)。FISH在51例中的16例(31%)中检测到17例IGH易位。在13例add(14)(q32)病例中,FISH在9例(69%)中鉴定出了伙伴染色体(3q27,6例;2p13、19p13.3和18q21.3,各1例)。在38例(16%)14q32无明显改变的患者中,有6例,在13例(15%)一条14号染色体异常的患者中有2例存在隐匿(5例)或隐匿性IGH易位(3例),涉及3q27(3例)、5p15.3(2例)、19p13.3(3例)或14q32(1例;1例患者有两种重排)。我们鉴定出了两种新的、复发性的隐匿易位:t(5;14)(p15.3;q32)(2例)和t(14;19)(q32;p13.3)(3例)。总之,回顾性分析显示,FISH能够在大约20%的14q32无明显重排的淋巴瘤病例中检测到隐匿或隐匿性IGH重排。